Gainers
- Helius Medical Technologies, Inc. (NASDAQ:HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.
- Eargo, Inc. (NASDAQ:EAR) shares rose 148% to $1.74 in pre-market trading. The company is scheduled to report Q2 earnings on Monday, August 8.
- Applied DNA Sciences, Inc. (NASDAQ:APDN) shares rose 63% to $4.57 in pre-market trading after jumping 297% on Tuesday. Applied DNA Sciences initiated analytical validation of a company-developed, PCR-based monkeypox virus test specific to the genetic signature of the monkeypox virus.
- Tuniu Corporation (NASDAQ:TOUR) shares rose 61% to $1.30 in pre-market trading after dropping over 9% on Tuesday.
- Chembio Diagnostics, Inc. (NASDAQ:CEMI) shares rose 52.1% to $1.11 in pre-market trading. Chembio Diagnostics is expected to release financial results for the second quarter after the close of trading on Thursday, August 4, 2022.
- AMTD IDEA Group (NYSE:AMTD) rose 35% to $9.46 in pre-market trading after jumping over 236% on Tuesday.
- MediaCo Holding Inc. (NASDAQ:MDIA) rose 35% to $5.14 in pre-market trading after climbing around 14% on Tuesday. Standard General recently purchased roughly 12.9 million shares, bringing ownership to 92.4%.
- SemiLEDs Corporation (NASDAQ:LEDS) rose 32% to $4.30 in pre-market trading.
- Otonomy, Inc. (NASDAQ:OTIC) rose 28.8% to $0.3213 in pre-market trading. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
- Connexa Sports Technologies Inc. (NASDAQ:CNXA) rose 26.8% to $1.37 in pre-market trading after jumping 20% on Tuesday.
- Ocean Power Technologies, Inc. (NASDAQ:OPTT) rose 23.3% to $1.27 in pre-market trading after surging 10% on Tuesday.
- Talis Biomedical Corporation (NASDAQ:TLIS) rose 23% to $0.94 in pre-market trading after reporting a sharp rise in Q2 sales.
- Crawford & Company (NYSE: CRD-B) shares rose 23% to $8.71 in pre-market trading. The company’s board declared a quarterly dividend of $0.06 per share on the Class A Common Stock and $0.06 per share on the Class B Common Stock.
- China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) rose 19.2% to $1.99 in pre-market trading after gaining more than 14% on Tuesday.
- Precipio, Inc. (NASDAQ:PRPO) rose 16.3% to $1.71 in pre-market trading after surging around 25% on Tuesday.
- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares rose 14.7% to $0.4705 in pre-market trading.
- PayPal Holdings, Inc. (NASDAQ:PYPL) rose 12% to $100.35 in pre-market trading after the company reported better-than-expected Q2 results and raised FY22 EPS guidance.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 12% to $2.71 in pre-market trading. Faraday Future Intelligent Electric recently signed a non-binding term sheet agreement with a major shareholder, FF Top Holding LLC, for a proposed convertible term loan facility.
- Alteryx, Inc. (NYSE:AYX) rose 11.7% to $56.48 in pre-market trading following strong Q2 results.
- Coherus BioSciences, Inc. (NASDAQ:CHRS) rose 10.6% to $11.08 in pre-market trading as the FDA approved the company’s CIMERLI as the first and only interchangeable biosimilar to lucentis for all five indications, with 12 months of interchangeability exclusivity.
- SoFi Technologies, Inc. (NASDAQ:SOFI) rose 10% to $7.05 in pre-market trading after the company reported better-than-expected Q2 results and raised FY22 guidance.
- Akso Health Group (NASDAQ:AHG) rose 10% to $1.04 in pre-market trading.
- Amicus Therapeutics, Inc. (NASDAQ:FOLD) rose 8.8% to $10.84 in pre-market trading. Amicus Therapeutics is expected to report Q2 results on Thursday, August 4, 2022.
- Second Sight Medical Products, Inc. (NASDAQ:EYES) rose 7.2% to $1.93 in pre-market trading.
